> 6 In clinical studies, alogliptin had no clini cally relevant effect on the pharmacokinetics of CAFFEINE, (R)-WARFARIN , PIOGLITAZONE, GLYBURIDE, TOLBUTAMIDE, (S)-WARFARIN, DEXTROMETHORPHAN, ATORVASTATIN, MIDAZOLAM, an oral contraceptive (NORETHINDRONE and ethinyl oestradiol), DIGOXIN, FEXOFENADINE, METFORMIN, or CIMETIDINE , thus providing in  vivo  evidence of a low propensity to cause interaction with substrates of CYP1A2, CYP3A4, CYP2D6, CYP2C9, p- glycoprotein, and OCT2.
